A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity
Eleftherios Kostaras(Institute of Cancer Research), Igor Vivanco(Institute of Cancer Research)
Cited by 37
Related Papers
DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF
|Life Science Alliance|2022|17
Glucose deprivation induces cancer cell death through oncogene overdose
|Research Square|2026|0